Form AW - Amendment Withdrawal Request
2024年12月13日 - 10:10PM
Edgar (US Regulatory)
LUMOS PHARMA, INC.
4200 Marathon Blvd., Suite 200
Austin, Texas 78756
December 13,
2024
VIA EDGAR
Office of Life Sciences
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Request for Withdrawal of Filing of POS AM with respect to Form S-3 (Registration No. 333-239137)
Ladies and Gentlemen:
On behalf of Lumos Pharma, Inc. (the Company), we hereby submit this letter to notify the Securities and Exchange Commission (the SEC)
of an inadvertent EDGAR filing submission error. On December 12, 2024, the Company filed with the SEC (via EDGAR) Post-Effective Amendment No. 1 to Form S-3 File
No. 333-239137. Such filing was part of an omnibus filing terminating all of the Registration Statements on Form S-3 of the Company. However, Form S-3 File No. 333-239137 was withdrawn before effectiveness and therefore, no post-effective amendment to terminate such Registration Statement is needed. Pursuant to Rule
477 under the Securities Act of 1933, as amended, the Company hereby withdraws the Post-Effective Amendment No. 1 to Form S-3 of the Company filed on December 12, 2024 solely with respect to Form S-3 File No. 333-239137. The Company hereby confirms that that no securities were sold in connection with any offering pursuant to Form
S-3 File No. 333-239137.
Thank you for your assistance with this
matter. If you have any questions or comments concerning this request, please call me at (515) 598-2998.
Sincerely,
|
/s/ Brad Powers |
Brad Powers General Counsel |
Lumos Pharma (NASDAQ:LUMO)
過去 株価チャート
から 11 2024 まで 12 2024
Lumos Pharma (NASDAQ:LUMO)
過去 株価チャート
から 12 2023 まで 12 2024